OpiCalc Logo

OpiCalc

989 Clinical Tools

Logo
OpiCalc
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

ProtocolsAboutPrivacyTerms

Modified Duke Criteria

Endocarditis Diagnostic Standard • Modified Duke

Evidence Pending

Select clinical and lab findings to determine IE diagnostic probability.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Clinical Utility

Diagnosis of suspected Infective Endocarditis (IE) in patients with bacteremia or fever of unknown origin.
Standardization of findings across clinical, microbiological, and imaging (Echo/TEE) domains.
Evaluation of patients with new pathologic heart murmurs or embolic events.
Section 2

Formula & Logic

Major Criteria Detail

Blood CulturesTypical IE organisms (e.g. S. viridans, HACEK) from 2 separate cultures.
EchocardiogramOscillating intracardiac mass, abscess, or new partial dehiscence of prosthetic valve.
SerologySingle positive blood culture for Coxiella burnetii or IgG antibody titer > 1:800.

Minor Criteria Detail

PredispositionProsthetic valve, prior IE, cyanotic CHD, or IV drug use.
VascularArterial emboli, septic pulmonary infarcts, Janeway lesions.
ImmunologicalGlomerulonephritis, Osler nodes, Roth spots, Rheumatoid Factor.
Section 3

Pearls/Pitfalls

TEE vs. TTE

Transesophageal Echocardiography (TEE) is significantly more sensitive than TTE (90% vs 60%) for detecting vegetations and is mandatory in patients with prosthetic valves or complex anatomy.

Culture-Negative IE

Prior antibiotic use is the most common cause of culture-negative results.
Fastidious organisms (HACEK group) may require extended incubation (>7 days).
Consider Bartonella, Legionella, or Brucella serology if suspicion remains high.
Section 4

Next Steps

Definite IE Management

01
Initiate prolonged course of IV antibiotics (usually 4–6 weeks).
02
Consult Cardiology and Infectious Disease immediately.
03
Assess for surgical indications (Heart failure, large vegetations >10mm, or fungal IE).
04
Monitor for embolic complications (Stroke, splenic infarct).
Section 5

Evidence Appraisal

Primary Reference

Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Li JS et al. • Clin Infect Dis.. 2000;n=810. The 2000 modification incorporated TEE findings and Coxiella serology, significantly improving sensitivity over the original 1994 Duke criteria.

Section 6

Literature

From Beth Israel to Duke

The journey of IE diagnosis began with the Von Reyn criteria in 1981, which relied heavily on surgery or autopsy. In 1994, Durack and colleagues at Duke University moved the needle toward clinical diagnosis. The "Modified" version we use today (published by Li et al. in 2000) was the first to recognize the diagnostic power of the Transesophageal Echo (TEE), transforming IE from a surgical diagnosis to a bedside one.

Last Comprehensive Review: 2026

Guidelines & Evidence

Clinical Details

Section 1

Major Criteria

Microbiological Evidence

["Blood cultures positive for IE from 2 separate BCs (typical organisms).","Persistently positive BCs (12h apart or 3 of 4).","Single positive BC for Coxiella burnetii or phase I IgG > 1:800."]

Endocardial Involvement

["Echocardiogram positive for IE (vegetation, abscess, new valvular regurgitation, or dehiscence of prosthetic valve)."]
Section 2

Minor Criteria

Predisposition / Fever

["Predisposing heart condition or IV drug use.","Fever ≥ 38.0°C (100.4°F)."]

Vascular Phenomena

Emboli, septic infarcts, mycotic aneurysm, Janeway lesions.

Immunologic Phenomena

Glomerulonephritis, Osler nodes, Roth spots, Rheumatoid factor.

Microbiological evidence

Positive blood cultures not meeting major criteria.
Section 3

Definite IE

Clinical Requirements

["2 Major criteria","1 Major + 3 Minor criteria","5 Minor criteria"]

Last Comprehensive Review: 2026

Related Cardiovascular Tools

HAS-BLED
HEART Pathway
HEART Score
HEMORR2HAGES
hs-Troponin 0h/1h ESC Algorithm
Hypertension Staging
iFR
INTERCHEST Score
Killip Classification
Lee's RCRI
Have feedback about this calculator?Let us know.